Newsweek reports that anaplasmosis cases are appearing in new regions as black-legged ticks expand their range northward. Canada now ranks anaplasmosis as its second most common tick-borne disease. A recent case study in the Canadian Medical Association Journal documented severe complications, including myocarditis, signaling that clinicians need faster recognition protocols.
Most people recognize Lyme disease by name. Anaplasmosis does not have that brand recognition, which means delayed diagnosis and missed treatment windows. For patients in newly affected regions—summer workers, outdoor enthusiasts, rural communities—the gap between symptom onset and correct identification can mean the difference between outpatient care and hospitalization.
Health agencies and local newsrooms need to treat anaplasmosis as a recurring public health beat rather than a seasonal scare story. Expect expanded tick guidance in states like Tennessee where clinicians already see the trend, and whether primary care providers get training on anaplasmosis symptoms before the next wave hits.
Public awareness runs on brand recognition, and Lyme owns the category. When coverage treats every new tick-borne threat as a one-off curiosity tied to beach season, audiences get jump-scares instead of maps. The job now is less alarm than repetition: tell people where the ticks are, what symptoms to watch for, and which diseases their doctors are actually seeing. A 79-year-old with myocarditis doesn't care about the headline—they care that someone told them to get checked.
Filed to the Media desk · Jul 13